Aledade, Inc. · 5 months ago
Growth Development Sales Representative I, Remote
Aledade is a public benefit corporation focused on empowering independent primary care. The Growth Development Representative I will drive network growth by generating and qualifying leads, collaborating with the sales team, and exceeding lead generation quotas.
Health CareMedicalPrimary and Urgent CareWellness
Responsibilities
Conduct outbound prospecting activities, including cold calling, emailing, and social selling, to generate leads within the primary care sector
Qualify leads by understanding practice needs and assessing their fit for Aledade's value-based care model
Collaborate with the sales team to develop targeted outreach strategies and campaigns, while maintaining accurate records of all prospecting activities in our CRM system and activity system outreach.io
Meet and exceed monthly and quarterly quotas for qualified lead generation
Stay updated on industry trends and Aledade's solutions to effectively communicate value propositions to prospects
Qualification
Required
Bachelor's degree in business, health care, or a related field
2+ years of experience in sales, business development, or a similar role within the healthcare industry
Preferred
Excellent communication skills, both written and verbal
Strong interpersonal skills with the ability to build rapport quickly
Goal-oriented mindset with a drive to achieve and exceed targets
Ability to thrive in a fast-paced, team-oriented environment
Benefits
Health, dental and vision insurance paid up to 80% for employees, dependents and domestic partners
Robust time-off plan (21 days of PTO in your first year)
Two paid volunteer days and 11 paid holidays
12 weeks paid parental leave for all new parents
Six weeks paid sabbatical after six years of service
Educational Assistant Program and Clinical Employee Reimbursement Program
401(k) with up to 4% match
Stock options
And much more!
Company
Aledade, Inc.
Aledade is the largest network of independent primary care, enabling clinicians to deliver better patient outcomes and generate more savings revenue through value-based care.
Funding
Current Stage
Late StageTotal Funding
$1.18BKey Investors
Ares Commercial FinanceLightspeed Venture PartnersOMERS Growth Equity
2025-12-01Debt Financing· $500M
2023-06-21Series F· $260M
2022-06-06Series E· $123M
Recent News
2025-12-29
Company data provided by crunchbase